“Spironolactone; the ultimate blocker of RAAS cascade in hypertensive patients with special reference to its cardiovascular benefits: Revisiting the forgotten ways”, Bangladesh J Med Sci, vol. 11, no. 2, pp. 80–86, Jul. 2012, doi: 10.3329/bjms.v11i2.8664.